A carregar...
Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats
BACKGROUND: Abaloparatide is a parathyroid hormone receptor agonist that increases bone formation and reduces vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis. Animal studies indicate abaloparatide stimulates vertebral bone formation and enhances bony bridging and b...
Na minha lista:
| Publicado no: | JOR Spine |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7984001/ https://ncbi.nlm.nih.gov/pubmed/33778406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jsp2.1132 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|